Revenue (Tables)

6 Months Ended

Mar. 31, 2024

Revenue from Contract with Customer [Abstract]

Summary of Disaggregation of Revenue Within Reportable Segment

The following table is a disaggregation of revenue within each reportable segment.

	Three Months Ended March 31,				Six Months Ended March 31,
(In thousands)	2024		2023		2024		2023
Medical Device
Product sales	$	11,100	$	7,914	$	23,050	$	16,294
Royalties & license fees – performance coatings		10,323		8,098		18,531		15,567
License fees – SurVeil DCB		1,088		1,331		2,059		2,627
Research, development and other		2,315		2,364		4,731		4,237
Medical Device Revenue		24,826		19,707		48,371		38,725
In Vitro Diagnostics
Product sales		6,999		7,436		13,876		13,290
Research, development and other		133		55		263		116
In Vitro Diagnostics Revenue		7,132		7,491		14,139		13,406
Total Revenue	$	31,958	$	27,198	$	62,510	$	52,131